Nom du produit:4-(5-bromo-1H-indazol-3-yl)morpholine
IUPAC Name:5-bromo-3-(morpholin-4-yl)-1H-indazole
- CAS：552331-28-9
- Formule moléculaire：C11H12BrN3O
- Pureté：95%
- Numéro de catalogue：CM150210
- Poids moléculaire：282.14
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:552331-28-9
- Formule moléculaire:C11H12BrN3O
- Point de fusion:-
- Code SMILES:BrC1=CC2=C(NN=C2N3CCOCC3)C=C1
- Densité:
- Numéro de catalogue:CM150210
- Poids moléculaire:282.14
- Point d'ébullition:
- N° Mdl:MFCD13177000
- Stockage:Store at 2-8°C.
Category Infos
- Morpholines
- Morpholine contains secondary amine groups and has all the typical reactive characteristics of secondary amine groups. It can react with inorganic acids to form salts, and react with organic acids to form salts or amides, which can be subjected to alkylation reaction, and can also be reacted with ethylene oxide, ketone or Willgerodt reaction. Morpholine is a six-membered ring containing oxygen and nitrogen, and its alkalinity is much lower than that of its parent piperidine. The marketed morpholine drugs are mainly distributed in the fields of tumors, cardiovascular and cerebrovascular diseases, respiratory system diseases, digestive system diseases, infectious diseases and mental disorders.
- morpholine price
- if you are interested in morpholine price, please feel free to contact us. More information of our products will be forwarded to you upon receipt of your specific inquiry.
- Indazoles
- Indazoles are a class of organic heterocyclic compounds, also known as 1,2-diazaindene and benzopyrazole. Indazole is a good bioisomer of phenol, which is more lipophilic than phenol and less prone to phase I and II metabolism. Indazole derivatives have a wide range of biological activities, and it has been confirmed that indazole compounds have anti-tumor, analgesic, anti-inflammatory and other drug activities. Anticancer is the most important application field of indazole drugs. Renal cell carcinoma, solid tumor, nausea and vomiting caused by chemotherapy and leukemia are the main indications of this structural backbone drug.
Recherche 
+86 21 5895 0110 
